Keyword: Department of Health and Human Services (HHS)
Sen. Ron Wyden wants to know more about why Pfizer CEO Ian Read agreed to defer the company's July price hikes.
President Trump convinced one pharma giant to retreat on price increases, and it’s not good news for other price-hiking drugmakers.
CMS has pulled the plug on a plan to implement indication-specific pricing on Novartis' CAR-T drug Kymriah.
Alex Azar said drug companies are "actually competing with each other" to lower prices but want to make sure PBMs won't discriminate against them.
President Trump's new pick for CDC director voiced unequivocal support for immunizations.
President Donald Trump Monday pledged to soon unveil a plan for drug prices and said the DOJ is considering suing opioid companies.
Three people injected with an unauthorized herpes vaccine by a Southern Illinois University researcher have filed suit against his company.
Alex Azar is just one of hundreds who have glided through the "revolving door" between pharma and the federal government, Kaiser Health News found.
More than a year after starting to probe pharma's ties with patient assistance charities, the feds have secured their first sizable settlement.
A new report found that spending on pharmaceuticals grew at a much slower rate last year than in recent history.